|
Catalog #
|
Source:
|
Lot #
|
Size:
|
|
AP8140a
|
Rabbit
|
SH030814E
|
0.1 mg
|
|
Concentration:
|
Accession:
|
Clone Name:
|
Isotype:
|
|
0.25 mg/ml
|
P52789
|
RB3917
|
Rabbit Ig
|
|
Applications:
|
Reactivity:
|
MW (kDa):
|
|
WB, IHC, E
|
H
|
102367 Da
|
|
Target/Specificity:
|
|
This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human HK2.
|
|
Other Names:
|
|
Hexokinase, type II; HK II; Muscle form hexokinase
|
|
Application Data:
|
The anti-HK2 Pab (Cat. #AP8140a) is used in Western blot to detect HK2 in A375 cell lysate. |
Formalin-fixed and paraffin-embedded human skeletal muscle tissue reacted with HK2 antibody (N-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. |
|
|
Background:
|
|
In vertebrates there are four major glucose-phosphorylating isoenzymes, designated hexokinase I, II, III, and IV. Hexokinase is an allosteric enzyme inhibited by its product GLC-6-P. Hexokinase activity is involved in the first step in several metabolic pathways. HK3 is bound to the outer mitochondrial membrane. Its hydrophobic N-terminal sequence may be involved in membrane bindng. It is the predominant hexokinase isozyme expressed in insuline-responsive tissues such as skeletal muscle. The N- and C-terminal halves of this hexokinase show extensive sequence similarity to each other. The catalytic activity is associated with the C-terminus while regulatory function is associated wiht the N-terminus. Although found in NIDDM patients, genetic variations of HK2 do not contribute to the disease.
|
|
Background References:
|
- Lehto, M., et al., Diabetologia 38(12):1466-1474 (1995).
- Vidal-Puig, A., et al., Diabetes 44(3):340-346 (1995).
- Laakso, M., et al., Diabetes 44(3):330-334 (1995).
- Echwald, S.M., et al., Diabetes 44(3):347-353 (1995).
- Shinohara, Y., et al., Cancer Lett. 82(1):27-32 (1994).
|
|
Product Citations:
|
- Diane Palmieri, et al. Mol. Cancer Res. 2009; 7:1438-1445.
|
|
Application Notes:
|
| The suggested dilution is: | |
| ELISA | 1:1,000 |
| Western blotting | 1:100~500 |
| Immunohistochemistry | 1:50~100 |
|
|
Format:
|
|
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
|
|
Storage:
|
|
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
|
|
Precautions:
|
|
This product is for research use only. Not for use in diagnostic
or therapeutic procedures.
|